Diabetic Nephropathy

Renalytix highlights study using risk assessment test for diabetic kidney disease

Researchers evaluated the effectiveness of a care management program focused on treating diabetic kidney disease patients in the earliest stages of the disease before significant kidney function loss or other complications have developed.

December 1, 2022

Renalytix to present at American Society of Nephrology Kidney Week

The presentations will include a cost-effectiveness analysis supporting population-based KidneyIntelX testing for Medicare patients, as well as findings from a multiyear study at a major healthcare system highlighting disparities in healthcare access.

October 17, 2022

ADA lowers optimal blood sugar levels for kids

The recommendation was published in Diabetes Care in a review article by Dr. Maria J. Redondo, a pediatric endocrinologist at Texas Children's Hospital and professor at Baylor College of Medicine, as well as Dr. Sarah Lyons, pediatric endocrinologist at Texas Children's and assistant professor at Baylor College of Medicine.

January 14, 2021

Blood test spots diabetes complications early on

The development is significant for patients with type 2 diabetes because if vascular complications, such as heart disease, atherosclerosis, or kidney failure, are detected at an early stage, preventive treatments could be given to avoid severe clinical outcomes down the line.

October 1, 2019

Most Popular

Genetic causes identified for three rare diseases

Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease

FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis

National hepatitis C elimination program represents an historic opportunity, according to White House

Chicago man indicted for COVID-19 testing fraud

Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test